These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2767790)

  • 1. Normalization of serum prolactin levels in hemodialysis patients on recombinant human erythropoietin.
    Schaefer RM; Kokot F; Kuerner B; Zech M; Heidland A
    Int J Artif Organs; 1989 Jul; 12(7):445-9. PubMed ID: 2767790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved sexual function in hemodialysis patients on recombinant erythropoietin: a possible role for prolactin.
    Schaefer RM; Kokot F; Wernze H; Geiger H; Heidland A
    Clin Nephrol; 1989 Jan; 31(1):1-5. PubMed ID: 2914405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of recombinant human erythropoietin (r-HuEPO) therapy on plasma FT3, FT4, TSH, FSH, LH, free testosterone and prolactin levels in hemodialysis patients.
    Yeksan M; Tamer N; Cirit M; Türk S; Akhan G; Akkus I; Erkul I
    Int J Artif Organs; 1992 Oct; 15(10):585-9. PubMed ID: 1428205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in sex hormones and sexual function of patients with renal failure treated with recombinant human erythropoietin.
    Suzuki H; Murakami M; Ichihara A; Saruta T
    Nihon Jinzo Gakkai Shi; 1992 Jan; 34(1):79-84. PubMed ID: 1593800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An echocardiographic study of the left ventricular functional indices in pediatric patients on hemodialysis and in treatment with recombinant human erythropoietin (r-HuEPO)].
    Seracini D; Pollini I; Lavoratti GC; Pela I; Materassi M; Danti D; De Simone L; Favilli S; Manetti A
    Pediatr Med Chir; 1994; 16(4):389-92. PubMed ID: 7816703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The treatment of anemia of hemodialysis patients using recombinant human erythropoietin: comparison between intravenous and subcutaneous administration].
    Zehnder C; Blumberg A
    Schweiz Med Wochenschr; 1990 Feb; 120(7):217-20. PubMed ID: 2309110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal function during erythropoietin therapy for anemia in predialysis chronic renal failure patients.
    Abraham PA; Opsahl JA; Rachael KM; Asinger R; Halstenson CE
    Am J Nephrol; 1990; 10(2):128-36. PubMed ID: 2349956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human recombinant erythropoietin treatment in transfusion dependent anemic patients on maintenance hemodialysis.
    Zehnder C; Blumberg A
    Clin Nephrol; 1989 Feb; 31(2):55-9. PubMed ID: 2920469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of erythropoietin on gonadotropic hormones and sexual function in patients on hemodialysis].
    Resić H; Alajbegović A; Sahović V; Suljić E; Mesić E; Javorić R
    Med Arh; 2004; 58(2):113-5. PubMed ID: 15202320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multicenter study of darbepoetin alfa in the treatment of anemia secondary to chronic renal insufficiency on dialysis].
    Martínez Castelao A; Reyes A; Valdés F; Otero A; López de Novales E; Pallardó L; Tabernero JM; Hernández Jaras J; Lladós F
    Nefrologia; 2003; 23(2):114-24. PubMed ID: 12778875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring considerations in recombinant human erythropoietin therapy.
    Ogden DA
    Semin Nephrol; 1989 Mar; 9(1 Suppl 2):12-5. PubMed ID: 2669080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of the anemia of hemodialysis patients with recombinant human erythropoietin.
    Schaefer RM; Kuerner B; Zech M; Denninger G; Borneff C; Heidland A
    Int J Artif Organs; 1988 Jul; 11(4):249-54. PubMed ID: 3410565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effects of r-HuEPO on platelet function and coagulation factors in hemodialysis patients].
    Kinugasa E; Nabeshima K; Niikura K; Kawabe S; Akizawa T; Kitaoka T; Koshikawa S
    Nihon Jinzo Gakkai Shi; 1990 Oct; 32(10):1109-16. PubMed ID: 2287103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Who should receive recombinant human erythropoietin?
    Van Stone JC
    Semin Nephrol; 1989 Mar; 9(1 Suppl 2):3-7. PubMed ID: 2669084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerance of treatment with recombinant-human erythropoietin in chronic renal failure (pre-dialysis) patients.
    Frenken LA; Verberckmoes R; Michielsen P; Koene RA
    Nephrol Dial Transplant; 1989; 4(9):782-6. PubMed ID: 2516609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of recombinant human erythropoietin on renal function in humans.
    Lim VS; Fangman J; Flanigan MJ; DeGowin RL; Abels RT
    Kidney Int; 1990 Jan; 37(1):131-6. PubMed ID: 2299799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human erythropoietin treatment may improve quality of life and cognitive function in chronic hemodialysis patients.
    Wolcott DL; Marsh JT; La Rue A; Carr C; Nissenson AR
    Am J Kidney Dis; 1989 Dec; 14(6):478-85. PubMed ID: 2596475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
    Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC
    J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of renal anemia by erythropoietin substitution. The effects on the cardiovascular system.
    Radermacher J; Koch KM
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S56-60. PubMed ID: 8608665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of erythropoietin treatment on gonadotropic hormone levels and sexual function in male uremic patients.
    Wu SC; Lin SL; Jeng FR
    Scand J Urol Nephrol; 2001 Apr; 35(2):136-40. PubMed ID: 11411657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.